Advertisement

The Scientist

» open access and immunology

Most Recent

image: Speaking of Science

Speaking of Science

By | August 1, 2012

August 2012's selection of notable quotes

3 Comments

image: Survival of the Fittest (to print)

Survival of the Fittest (to print)

By | August 1, 2012

Science publishing is locked in an evolutionary arms race as it edges further into the digital age.

5 Comments

image: Whither Science Publishing?

Whither Science Publishing?

By | August 1, 2012

As we stand on the brink of a new scientific age, how researchers should best communicate their findings and innovations is hotly debated in the publishing trenches.

18 Comments

image: Skin Microbes Alter Immunity

Skin Microbes Alter Immunity

By | July 30, 2012

Like commensal gut organisms, skin microbiota appear to help the mammalian immune system mature and stay regulated.

0 Comments

image: Ubiquitin Chains in Action

Ubiquitin Chains in Action

By | July 1, 2012

Present in every tissue of the body, ubiquitin appears to be involved in a dizzying array of functions, from cell cycle and division to organelle and ribosome biogenesis, as well as the response to viral infection. The protein plays at least two role

0 Comments

image: UK to Enforce Paper Sharing

UK to Enforce Paper Sharing

By | June 29, 2012

The United Kingdom's Wellcome Trust announces that it will begin sanctioning researchers who do not submit manuscripts to the public UK PubMed Central database.

0 Comments

image: UK Gov’t Supports Open Access Plan

UK Gov’t Supports Open Access Plan

By | June 19, 2012

The UK government releases its recommendation that open access be “the main vehicle for the publication of research,” though it warns of the costs that could entail.

0 Comments

image: The Publishing Buffet

The Publishing Buffet

By | June 13, 2012

An open-access journal with an all-you-can-publish fee structure announces its launch.

0 Comments

image: The Fungus Among Us

The Fungus Among Us

By | June 11, 2012

Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.

1 Comment

image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Vector Laboratories
Vector Laboratories